What is it about?
Targeting estrogen receptor signaling combined with targeted NO• release represents a promising therapeutic approach in malignant melanoma that has potential to prevent metastatic spread and reduce tumor growth.
Featured Image
Photo by Bruno Nascimento on Unsplash
Read the Original
This page is a summary of: Therapeutic Potential of Nitric Oxide releasing Selective Estrogen Receptor Modulators (NO-SERMs) in Malignant Melanoma, Journal of Investigative Dermatology, January 2022, Elsevier,
DOI: 10.1016/j.jid.2021.12.028.
You can read the full text:
Contributors
The following have contributed to this page
